CENCI, SIMONE
 Distribuzione geografica
Continente #
AS - Asia 1.538
EU - Europa 1.525
NA - Nord America 1.378
SA - Sud America 266
Continente sconosciuto - Info sul continente non disponibili 119
AF - Africa 36
OC - Oceania 1
Totale 4.863
Nazione #
US - Stati Uniti d'America 1.293
RU - Federazione Russa 995
SG - Singapore 592
CN - Cina 507
BR - Brasile 218
HK - Hong Kong 158
VN - Vietnam 142
IT - Italia 136
SE - Svezia 79
FR - Francia 75
DE - Germania 73
CA - Canada 45
GB - Regno Unito 44
FI - Finlandia 38
IN - India 33
BD - Bangladesh 26
MX - Messico 23
PL - Polonia 20
ES - Italia 18
AR - Argentina 16
TR - Turchia 14
JP - Giappone 13
ZA - Sudafrica 13
AT - Austria 11
EC - Ecuador 11
NL - Olanda 11
AE - Emirati Arabi Uniti 8
LT - Lituania 7
MY - Malesia 7
ID - Indonesia 6
UZ - Uzbekistan 6
CO - Colombia 5
IQ - Iraq 5
PE - Perù 5
PK - Pakistan 5
KE - Kenya 4
UA - Ucraina 4
UY - Uruguay 4
BB - Barbados 3
ET - Etiopia 3
HN - Honduras 3
JM - Giamaica 3
PY - Paraguay 3
SN - Senegal 3
CH - Svizzera 2
CL - Cile 2
DZ - Algeria 2
EG - Egitto 2
HU - Ungheria 2
IE - Irlanda 2
MA - Marocco 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PH - Filippine 2
SV - El Salvador 2
TH - Thailandia 2
TN - Tunisia 2
VE - Venezuela 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BE - Belgio 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CU - Cuba 1
CZ - Repubblica Ceca 1
GT - Guatemala 1
HR - Croazia 1
IR - Iran 1
IS - Islanda 1
JO - Giordania 1
KG - Kirghizistan 1
LY - Libia 1
MD - Moldavia 1
MG - Madagascar 1
MK - Macedonia 1
NG - Nigeria 1
NI - Nicaragua 1
QA - Qatar 1
RO - Romania 1
SA - Arabia Saudita 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 4.744
Città #
Singapore 327
Moscow 210
Ashburn 209
San Jose 183
Hong Kong 156
Dallas 121
Shanghai 89
Council Bluffs 67
Hefei 62
Beijing 59
New York 55
Lauterbourg 50
Ho Chi Minh City 48
Los Angeles 47
Hanoi 34
Santa Clara 32
Milan 31
Boardman 26
Lawrence 26
Princeton 26
Helsinki 22
São Paulo 22
Montreal 21
Chennai 19
Munich 19
Orem 19
Warsaw 18
Boston 15
Chicago 14
Denver 14
Atlanta 13
London 13
Manchester 13
Nuremberg 13
Stockholm 13
Frankfurt am Main 12
The Dalles 12
Brooklyn 11
Johannesburg 11
Mexico City 11
Tokyo 11
Da Nang 9
Falkenstein 9
Tianjin 9
Guangzhou 8
Rio de Janeiro 8
Rome 8
San Francisco 8
Seattle 8
Turku 8
Ankara 7
Brasília 7
Florence 7
Lappeenranta 7
Washington 7
Belo Horizonte 6
Dubai 6
Houston 6
Phoenix 6
Poplar 6
Buffalo 5
Guayaquil 5
Monza 5
Porto Alegre 5
Rho 5
Shenzhen 5
Tashkent 5
Verona 5
Wuxi 5
Amsterdam 4
Bogotá 4
Brescia 4
Dhaka 4
Haiphong 4
Lima 4
Montevideo 4
Ottawa 4
Quito 4
The Bronx 4
Vienna 4
Bridgetown 3
Buenos Aires 3
Calgary 3
Cesano Boscone 3
Changsha 3
Charleston 3
Charlotte 3
Chengdu 3
Curitiba 3
Dakar 3
Fortaleza 3
Foshan 3
Guarulhos 3
Hangzhou 3
Kansas City 3
Kuala Lumpur 3
Milwaukee 3
Nairobi 3
Nha Trang 3
Paris 3
Totale 2.463
Nome #
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 153
A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells 143
A novel proteomic signature of osteoclast differentiation unveils the deubiquitinase UCHL1 as a necessary osteoclastogenic driver 138
Autophagy mediates epithelial cancer chemoresistance by reducing p62/SQSTM1 accumulation 129
3D culture of Erdheim-Chester disease tissues unveils histiocyte metabolism as a new therapeutic target 118
HMGB1, an evolving pleiotropic protein critical for cellular and tissue homeostasis: role in aging and age-related diseases 116
Assessing Heterogeneity of Osteolytic Lesions in Multiple Myeloma by ¹H HR-MAS NMR Metabolomics. 114
Autophagy in Plasma Cell Ontogeny and Malignancy 111
MHC Class II Transactivator is an in vivo regulator of osteoclast differentiation and bone homeostasis co-opted from adaptive immunity 111
Mechanisms of hematopoietic clonal dominance in VEXAS syndrome 103
Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production 103
Biomarkers of aging in frailty and age-associated disorders: State of the art and future perspective 103
Iron increases the susceptibility of multiple myeloma cells to bortezomib 100
A New Fluorogenic Peptide Determines Proteasome Activity in Single Cells 99
Combined inhibition of p97 and the proteasome causes lethal disruption of the secretory apparatus in multiple myeloma cells 98
Pivotal Advance: Protein synthesis modulates responsiveness of differentiating and malignant plasma cells to proteasome inhibitors 98
Autophagy and longevity: Evolutionary hints from hyper-longevous mammals 95
Autophagy in plasma cell pathophysiology 94
CHOP-independent apoptosis and pathway-selective induction of the UPR in developing plasma cells 94
FAM46C-dependent tuning of endoplasmic reticulum capacity in Multiple Myeloma 92
Autophagy, a new determinant of plasma cell differentiation and antibody responses 92
Plasma cells require autophagy for sustainable immunoglobulin production 91
B lymphocytes inhibit human osteoclastogenesis by secretion of TGF beta 86
Dampening Ab responses using proteasome inhibitors following in vivo B cell activation 85
Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator 82
Editorial: Advances in Plasma Cells in Health and Disease 81
Autophagy in Plasma Cells 80
Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease 80
The amyloidogenic light chain is a stressor that sensitizes plasma cells to proteasome inhibitor toxicity 79
ROLE OF TRAINED IMMUNITY AND IMMUNOMETABOLISM IN THE PATHOGENESIS OF ERDHEIM-CHESTER DISEASE 73
Mutation of PFN1 Gene in an Early Onset, Polyostotic Paget-like Disease 72
Tight Junction Protein 1 Modulates Proteasome Capacity and Proteasome Inhibitor Sensitivity in Multiple Myeloma via EGFR/JAK1/STAT3 Signaling 72
Disease-relevant proteostasis regulation of cystic fibrosis transmembrane conductance regulator 71
Management of bone fragility in type 2 diabetes: Perspective from an interdisciplinary expert panel 69
IRON CONTRIBUTES TO BORTEZOMIB SENSITIVITY IN MULTIPLE MYELOMA CELLS 65
Preventive Role of Vitamin D Supplementation for Acute Phase Reaction after Bisphosphonate Infusion in Paget's Disease 65
The Interaction of the Tumor Suppressor FAM46C with p62 and FNDC3 Proteins Integrates Protein and Secretory Homeostasis 65
Hip fracture in nursing homes: An Italian study on prevalence latency, risk factors, and impact on mobility 62
Autophagy in the regulation of protein secretion in immune cells 62
Validation of the clinical consensus recommendations on the management of fracture risk in postmenopausal women with type 2 diabetes 60
Ex vivo gene expression of osteoblasts in maxillary sinus grafting 60
TENT5C/FAM46C modulation in vivo reveals a trade-off between antibody secretion and tumor growth in multiple myeloma 58
PROGRESSIVELY IMPAIRED PROTEASOMAL CAPACITY DURING TERMINAL PLASMA CELL DIFFERENTIATION 58
Magnesium-enriched hydroxyapatite versus autologous bone in maxillary sinus grafting: combining histomorphometry with osteoblast gene expression profiles ex vivo 57
Short-term reproducibility of proximal femur bone mineral density in the elderly 56
Toll-like receptor 9 stimulation can induce I kappa B zeta expression and IgM secretion in chronic lymphocytic leukemia cells 55
Proteasome stress sensitizes malignant pleural mesothelioma cells to bortezomib-induced apoptosis 53
Preclinical evidence of a direct pro-survival role of arginine deprivation in multiple myeloma 52
Managing and exploiting stress in the antibody factory 52
M-CSF neutralization and Egr-1 deficiency prevent ovariectomy-induced bone loss 50
The proteasome load versus capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibition 50
The Proteasome in Terminal Plasma Cell Differentiation 49
Therapeutic Efficacy of Hematopoietic Stem Cell Gene Therapy for Hurler Type 1 Mucopolysaccharidosis 48
Proteostenosis and Plasma Cell Pathophysiology 48
Recent advances and future directions in targeting the secretory apparatus in multiple myeloma 48
PROTEOSTASIS AS A SIGNALING DEVICE AND THERAPEUTIC TARGET 47
Metabolomics of B to Plasma Cell Differentiation 46
Role of TNF-alpha producing T-cells in bone loss induced by estrogen deficiency 45
Interleukin-7 stimulates osteoclast formation by up-regulating the T-cell production of soluble osteoclastogenic cytokines 44
The problem of arteriovenous malformations of the spinal cord in the elderly: Case report of an octogenarian 43
Proteotoxic stress and cell lifespan control 39
The role of autophagy in plasma cell ontogenesis 38
T cell activation induces human osteoclast formation via receptor activator of nuclear factor kappa B ligand-dependent and -independent mechanisms 37
The mitochondrial protease ClpP is a metabolic vulnerability and an immunogenic trigger against multiple myeloma 12
The HIF-1α Pathway Regulates Satellite Cell Fate During Aging Through Histone Lactylation 7
A wholesale approach to disarm multiple myeloma 6
null 1
Totale 4.863
Categoria #
all - tutte 26.519
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.519


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202218 0 0 2 6 1 3 3 0 3 0 0 0
2022/2023150 58 30 6 0 1 15 3 5 6 15 10 1
2023/2024317 38 27 56 28 16 34 9 35 0 7 12 55
2024/2025937 81 15 42 42 39 87 118 93 154 103 66 97
2025/20263.205 227 206 131 406 367 90 331 244 890 152 60 101
2026/2027217 101 116 0 0 0 0 0 0 0 0 0 0
Totale 4.863